Introduction
Although the political uncertainty has abated, Donald Trump has been able to single handily influence the movement of specific stocks [i.e. Lockheed Martin (NYSE:LMT), Ford (NYSE:F), Boeing (NYSE:BA) and others] and sectors (i.e. automotive, biotechnology, defense and healthcare). The overall healthcare sector has become volatile on the heels of any statement or tweet from Donald Trump. Case in point, Trump recently held a press conference and stated his stance with regard to the pharmaceutical industry and more specifically drug pricing. Trump stated that drug companies are "getting away with murder" when speaking to the drug pricing issue that has taken the spotlight. These remarks immediately resulted in a broad sell-off across the entire biotech cohort. The iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) shed more than 2.5% or $7 per share as these comments were heard during the live broadcast. The healthcare sector has been faced with a political backdrop that's put the entire industry on edge. The overall healthcare umbrella has become sensitive to any tweet from President Trump as he vows to bring down drug prices. As he pursues his agenda against drug pricing, much of these threats may have already been priced-in as seen in many healthcare related stocks [i.e. McKesson (NYSE:MCK), CVS (NYSE:CVS), AbbVie (NYSE:ABBV) and Allergan (NYSE:AGN)] that have seen sharp and sustained sell-offs. Lately, many large-cap pharma companies have create a drug pricing coalition of sorts to reign in transparency, separate themselves from a few bad actors and get out in front of Trump's crusade against the drug companies.
Figure 1 - IBB price activity over the previous 6 months with pronounced volatility that coincide with political rhetoric against drug pricing
Merck Joins Drug Pricing Coalition
Big pharma companies are joining forces as of late to address the price increases that the public and governmental officials have been demanding. Allergan, J&J (NYSE:JNJ), Novo Nordisk (NYSE:NVO) and AbbVie have committed to limiting any annual drug pricing increases to less than 10%. J&J went further stating that they will be publishing an annual report regarding its portfolio and the price increases they've implemented. AbbVie released data on its increases as well stating that Humira was increased by 8.4% with an only once annual increase moving forward. Merck (NYSE:MRK) becomes the latest pharma to join this drug pricing transparency coalition. Merck raised list prices by an average of 9.6% with an average net price increase of 5.5%
M&A and Repatriation Catalysts
The M&A activity has heated up as of late with J&J and McKesson making a big splash with acquisitions of Actelion and CoverMyMeds, respectively. Johnson & Johnson made an all-cash offer of $30 billion to acquire Swiss drug maker Actelion. This acquisition was approved unanimously by the boards of both companies and valuing the transaction at $280 per share, payable in U.S. dollars. This acquisition will be financed by cash held outside the U.S. while Actelion shares spiked 20% on the news. The drug discovery operations of Actelion will be spun off as a standalone company, termed R&D NewCo. Johnson & Johnson will own a 16% stake in the newly formed company with rights to an additional 16% ownership equity via a convertible note. McKesson reached an agreement to acquire privately-held healthcare IT company CoverMyMeds for $1.1 billion in an effort to strengthen its technology offerings to pharmaceutical manufactures, clinicians and payers. In addition to the latest moves, Pfizer's acquisition of Medivation for $14 billion, Allergan's acquisition of Tobira for $1.7 billion and J&J's acquisition of Abbott's Medical Optics unit for $4.3 billion. Recently, Ariad (NASDAQ:ARIA) Pharmaceuticals was acquired by Takeda Pharmaceuticals for $5.2 billion.
As campaign promises of repatriation of overseas assets and decreases in corporate taxes come to fruition, this could serve as a catalyst for M&A. These events taken in conjunction with chronically depressed valuations of many companies may accelerate M&A within the sector. The governmental stance on M&A activity may loosen up with the new administration while its pro-business agenda. Potential repatriation of overseas assets, decreases in corporate taxes and the loosening of M&A push back may bode well for the industry in the intermediate term. As the cohort remains suppressed, many prospective buyout candidates become more financially appealing to the acquirer due to beaten down valuations in concert with the maturity of pipelines coming into play. As this acquisition activity heats up, be on the lookout for stocks that have been rumored as takeover targets to heat up and possibly take IBB along for the ride.
Summary
As Donald Trump pursues his crusade against drug pricing, much of these threats may have already been priced-in as seen in many healthcare related stocks that have seen sharp and sustained sell-offs that have now leveled off. President Trump may be up against a formidable challenge with the formation of this new coalition on drug pricing transparency within large pharma. As transparency and responsible drug price increases enter the market, reigning in these costs may be more challenging when countered with this coalition and its vow to limit drug price increases. If this debate can be stymied by the coalition and largely put behind the industry, this cohort will likely rise. Potential M&A activity and a favorable repatriation environment can further support this sector. Collectively, all these potential events bode well for the sector and as IBB attempts to break through the $300 barrier be on the lookout for these events in propelling the index higher.
Disclosure: I am/we are long IBB.
I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Read more from the original source:
IBB: Merck Joins The Drug Pricing Coalition For Transparency - Seeking Alpha
- Plant biotechnology 3 - Video - January 1st, 2014 [January 1st, 2014]
- Press Release - April 9th, 2014 [April 9th, 2014]
- Biotech Suffers Record Exit at Largest ETF Signaling Turn - April 9th, 2014 [April 9th, 2014]
- Biotechnology World Congress 2014 | Biotechnology ... - April 9th, 2014 [April 9th, 2014]
- What is Biotechnology? - Access Excellence @ the National ... - April 9th, 2014 [April 9th, 2014]
- What is Biotechnology? - BIO | Healing, Fueling and ... - April 9th, 2014 [April 9th, 2014]
- Biotechnology - Wikipedia, the free encyclopedia - April 9th, 2014 [April 9th, 2014]
- IUBP Day5 2 Emerging Opportunities in Biotechnology - Video - April 9th, 2014 [April 9th, 2014]
- B.Tech(Biotechnology), BATCH 2008/09, SVPUAT MEERUT.............. FRIENDS FOREVER...... - Video - April 9th, 2014 [April 9th, 2014]
- Bharat Book Presents : Global Pharmaceutical & Biotechnology Outlook 2014 Mature Biotech - Video - April 9th, 2014 [April 9th, 2014]
- Bharat Book Presents : Global Pharmaceutical & Biotechnology Outlook 2014 Japan Pharma - Video - April 9th, 2014 [April 9th, 2014]
- Bharat Book Presents : Global Pharmaceutical & Biotechnology Outlook 2014 India Pharma - Video - April 9th, 2014 [April 9th, 2014]
- Bharat Book Presents : Global Pharmaceutical & Biotechnology Outlook 2014 Rising Stars - Video - April 10th, 2014 [April 10th, 2014]
- Nasdaq Rout Curbs 2000-Like Boom in Israeli Share Sales - April 15th, 2014 [April 15th, 2014]
- A Glimpse into Biotechnology - Video - April 15th, 2014 [April 15th, 2014]
- Biotechnology: gel electrophoresis, PCR - Video - April 15th, 2014 [April 15th, 2014]
- Plandai Biotechnology, Inc. Qualifies for Grant From South African Department of Trade - Video - April 16th, 2014 [April 16th, 2014]
- Biotechnology Program - University of California, Davis - April 17th, 2014 [April 17th, 2014]
- Biotechnology in Action (Arizona) - Video - April 17th, 2014 [April 17th, 2014]
- France protests new EU approved genetically modified corn ScienceDaily - Video - April 17th, 2014 [April 17th, 2014]
- Drug manufacture and Biotechnology '14 - SCOPS - final phase ( Auditing ) - Video - April 19th, 2014 [April 19th, 2014]
- Mucosis Partners With Chinese Firm Changchun BCHT Biotechnology - April 22nd, 2014 [April 22nd, 2014]
- Biotechnology-2014: Meeting the Needs of a Changing World - April 22nd, 2014 [April 22nd, 2014]
- New patenting guidelines are needed for biotechnology - April 22nd, 2014 [April 22nd, 2014]
- Biotechnology is so cool - Video - April 22nd, 2014 [April 22nd, 2014]
- Bharat Book Presents : Biotechnology Equipment Markets in China - Video - April 22nd, 2014 [April 22nd, 2014]
- New patenting guidelines needed for biotechnology, experts argue - April 24th, 2014 [April 24th, 2014]
- biotechnology videos - Video - April 24th, 2014 [April 24th, 2014]
- Kristi Snell, VP Research and Biotechnology for Metabolix, Inc. - Video - April 24th, 2014 [April 24th, 2014]
- 4th Annual International Conference: Advances in Biotechnology 2014 - Video - April 24th, 2014 [April 24th, 2014]
- Edmonds School District Biotechnology - Video - April 25th, 2014 [April 25th, 2014]
- World congress on Biotechnology - Video - April 25th, 2014 [April 25th, 2014]
- Bahir Dar university biotechnology dr tESFAYE - Video - April 25th, 2014 [April 25th, 2014]
- Algenist Skincare: Biotechnology from San Francisco - Video - April 27th, 2014 [April 27th, 2014]
- nitj biotechnology farewell batch2010-14 - Video - April 28th, 2014 [April 28th, 2014]
- Life Sciences & Biotechnology - Video - April 28th, 2014 [April 28th, 2014]
- Bolder Biotechnology Current Therapeutic Market Developmental Pipeline - Video - April 28th, 2014 [April 28th, 2014]
- Academic and Research Institutions to Play Key Role in 2014 BIO International Convention - April 29th, 2014 [April 29th, 2014]
- 19 Biotechnology - Video - April 29th, 2014 [April 29th, 2014]
- BIOTECHNOLOGY - Video - April 29th, 2014 [April 29th, 2014]
- Program Spotlight: Biotechnology - Video - April 30th, 2014 [April 30th, 2014]
- Biotechnology at Gaston College - Video - April 30th, 2014 [April 30th, 2014]
- Biotechnology - Gene Cloning - Video - April 30th, 2014 [April 30th, 2014]
- Amyris helps launch Brazilian Industrial Biotechnology Association (ABBI) - Video - May 2nd, 2014 [May 2nd, 2014]
- Julius Mugwagwa - Agro-biotechnology and Food Security - Video - May 2nd, 2014 [May 2nd, 2014]
- VIRUN's CEO, Philip Bromley, lecture - Cal Poly Pomona; Biotechnology - Video - May 2nd, 2014 [May 2nd, 2014]
- Biotechnology - gel electrophoresis - Video - May 2nd, 2014 [May 2nd, 2014]
- Plant Biotechnology Information Fair at Penn State 4/18/14 - Video - May 2nd, 2014 [May 2nd, 2014]
- Biotechnology ADHK - Video - May 2nd, 2014 [May 2nd, 2014]
- General Biology 2 - 38 Angiosperm Reproduction and Biotechnology - Flashcards - Video - May 2nd, 2014 [May 2nd, 2014]
- Impact of Biotechnology on Current Life - Video - May 3rd, 2014 [May 3rd, 2014]
- DGAP-Adhoc: Cytos Biotechnology Ltd to wind down Key Operational Activities - May 5th, 2014 [May 5th, 2014]
- Process - Genetic Engineering and Biotechnology - Video - May 6th, 2014 [May 6th, 2014]
- SAT105 Unit 3 Part 2 Biotechnology - Video - May 6th, 2014 [May 6th, 2014]
- highlights of industrial biotechnology - Video - May 6th, 2014 [May 6th, 2014]
- polymer & environmental biotechnology @ acib - Video - May 8th, 2014 [May 8th, 2014]
- SAT105 Unit 3 Part 1 Biotechnology - Video - May 8th, 2014 [May 8th, 2014]
- Talk of the Trade: Biotechnology & Health Sciences - Video - May 9th, 2014 [May 9th, 2014]
- Congratulations to the 2014 Biotechnology Graduates of Athens Technical College! - Video - May 9th, 2014 [May 9th, 2014]
- Plandai Biotechnology (PLPL) - Getting the Most Out of Nature - Video - May 10th, 2014 [May 10th, 2014]
- Stages Of Beans Growth- HU biotechnology - Video - May 11th, 2014 [May 11th, 2014]
- Revisiting the biotechnology stocks - Video - May 11th, 2014 [May 11th, 2014]
- Molecular Biotechnology - Master's Programme - Video - May 11th, 2014 [May 11th, 2014]
- Kevin Ahern's BB 350 (Biotechnology) 2014 - #22 - Video - May 12th, 2014 [May 12th, 2014]
- 5/5, Session 1 - Small biotechnology/Venture capital - Video - May 12th, 2014 [May 12th, 2014]
- Executive Interview - International Biotechnology Trust - Video - May 12th, 2014 [May 12th, 2014]
- Biotechnology Salaries | Salary.com - May 14th, 2014 [May 14th, 2014]
- Biotechnology | University of Wrocaw - Video - May 14th, 2014 [May 14th, 2014]
- JVS Bridges to College - Biotechnology Pathway Program - Video - May 16th, 2014 [May 16th, 2014]
- Biotechnology Paperslide Review by Khalizarek+Brian - Video - May 16th, 2014 [May 16th, 2014]
- Perceptions on the Future of Biotechnology by Robert Paarlberg (USA) - Video - May 16th, 2014 [May 16th, 2014]
- Plant Biotechnology - Video - May 16th, 2014 [May 16th, 2014]
- Playing with Biotechnology at the Age of 20: Kinshuk Mitra at TEDxOhioStateUniversity - Video - May 16th, 2014 [May 16th, 2014]
- biotechnology movie - Video - May 19th, 2014 [May 19th, 2014]
- New report details biotechnology's use in crops - May 20th, 2014 [May 20th, 2014]
- Biotechnology Stock Wins - Video - May 20th, 2014 [May 20th, 2014]
- Plant product of biotechnology - Video - May 21st, 2014 [May 21st, 2014]
- How Biotechnology Cure Diabetes - Video - May 22nd, 2014 [May 22nd, 2014]
- Exploring Laser-Material Interaction for Engineering, Biotechnology, and Medicine #DigInfo - Video - May 22nd, 2014 [May 22nd, 2014]
- Computers, Biotechnology, and Mass Communication - Video - May 22nd, 2014 [May 22nd, 2014]